Picture of Quantum Genomics SA logo

ALQGC — Quantum Genomics SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Quantum Genomics Announces Interim Analysis From Renal Failure Study

May 6 (Reuters) - QUANTUM GENOMICS SA  ALQGC.PA :
    * ANNOUNCES INTERIM ANALYSIS FROM STUDY OF FIRIBASTAT IN
RENAL
FAILURE PATIENTS

Source text for Eikon:  ID:nGNX4PnG71 
Further company coverage:  ALQGC.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Quantum Genomics SA

See all news